DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Edelfosine
Edelfosine
Lipid Raft-Mediated Akt Signaling As a Therapeutic Target in Mantle Cell Lymphoma
Membrane Lipid Therapy: Modulation of the Cell Membrane Composition and Structure As a Molecular Base for Drug Discovery and New Disease Treatment
Epirubicin Enhances TRAIL-Induced Apoptosis in Gastric Cancer Cells by Promoting Death Receptor Clustering in Lipid Rafts
Phosphoinositide Phosphatase SHIP-1 Regulates Apoptosis Induced by Edelfosine, Fas Ligation and DNA Damage in Mouse Lymphoma Cells Maaike C
Akt Inhibitors in Cancer Treatment: the Long Journey from Drug Discovery to Clinical Use (Review)
A Functional Genomic Screen in Saccharomyces Cerevisiae Reveals Divergent Mechanisms of Resistance to Different Alkylphosphochol
Antiprotozoal Activities of Phospholipid Analogues Simon L
Sensitivity of K562 and HL-60 Cells to Edelfosine, an Ether Lipid Drug, Correlates with Production of Reactive Oxygen Species1
Effect of Erufosine on Membrane Lipid Order in Breast Cancer Cell Models
Efficacy of Edelfosine Lipid Nanoparticles in Breast Cancer Cells a Author Affiliations
(12) Patent Application Publication (10) Pub. No.: US 2002/0102215 A1 100 Ol
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling
WO 2008/141480 Al
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
Ep 2505209 A1
Miltefosine Induces Programmed Cell Death in Leishmania Amazonensis Promastigotes
Stembook 2018.Pdf
Top View
Polymeric and Lipid Nanoparticles: Which Applications in Pediatrics?
Endoplasmic Reticulum Targeting in Ewing's Sarcoma by The
Gemcitabine and Edelfosine for the Treatment of Pediatric Cancer”
Cholesterol As a Factor Regulating the Influence of Natural (PAF And
1 Immunomodulatory Effects of the Ether Phospholipid Edelfosine in Experimental
Antitumor Alkyl-Lysophospholipid Analog Edelfosine Induces Apoptosis in Pancreatic Cancer by Targeting Endoplasmic Reticulum
Localization of Fas/CD95 Into the Lipid Rafts on Down-Modulation of the Phosphatidylinositol 3-Kinase Signaling Pathway
Mitochondrial Targeting Involving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine
Ether Lipid 1-O-Octadecyl-2-O-Methoxy-Rac
Phospholipids Into Mammalian Cells Antitumor and Bioactive Choline
Edelfosine Nanoemulsions Inhibit Tumor Growth of Triple Negative Breast Cancer in Zebrafsh Xenograft Model Sofa M
In Vitro and in Vivo Selective Antitumor Activity of Edelfosine Against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts
A New Class of Anticancer Alkylphospholipids Uses Lipid Rafts As Membrane Gateways to Induce Apoptosis in Lymphoma Cells
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Metabolomic and Lipidomic Profiling of the Effect of Edelfosine Treatment on Saccharomyces Cerevisiae
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
In Vitro and in Vivo Selective Antitumor Activity of Edelfosine Against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts
Antitumor Alkyl Ether Lipid Edelfosine: Tissue Distribution And
Some Antagonists of Platelet Activating Factor Are Cytotoxic for Human Malignant Cell Lines1
In Vitro and in Vivo Selective Antitumor Activity of Edelfosine Against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts
Pharmaceutical Appendix to the Tariff Schedule 2
Perifosine, a Novel Alkylphospholipid, Inhibits Protein Kinase B Activation
Customs Tariff - Schedule Xxi - 1
Miltefosine — Discovery of the Antileishmanial Activity of Phospholipid Derivatives
Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma
UC Berkeley UC Berkeley Electronic Theses and Dissertations
Wo 2007/044693 A2
(12) Patent Application Publication (10) Pub. No.: US 2006/0052438A1 H0 Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
Customs Tariff - Schedule Xxi - 1
NITRIC OXIDE Biology and Chemistry Nitric Oxide 10 (2004) 119–129
Ccr Pms 194 C/Pms 406 C
(12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
The Antitumor Ether Lipid Edelfosine (ET-18-O-CH3) Induces Apoptosis
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Samenvatting Engels
(12) United States Patent (10) Patent No.: US 8,968,730 B2 Koenig Et Al
Pharmaceuticals Appendix
Defining the Yeast Resistome Through in Vitro Evolution and Whole Genome Sequencing
Wo2018/191558
Anticancer Effects of Synthetic Phosphoethanolamine on Ehrlich Ascites Tumor: an Experimental Study